Ms. magazine  -- more than a magazine a movement

SIGN UP FOR MS. DIGEST, JOBS, NEWS AND ALERTS

FEMINIST WIRE NEWSBRIEFS

ABOUT
SEE CURRENT ISSUE
SHOP MS. STORE
MS. IN THE CLASSROOM
FEMINIST DAILY WIRE
FEMINIST RESOURCES
PRESS
JOBS AT MS.
READ BACK ISSUES
CONTACT
RSS (XML)
 
feminist wire | daily newsbriefs

November-10-03

FDA Panel to Consider EC Over-the-Counter Status

A Food and Drug Administration (FDA) panel will meet next month to consider over-the-counter sales status for the emergency contraceptive (EC) Plan B. New York-based Barr Laboratories, Inc. - which recently acquired Women's Capital Corporation, the manufacturer of Plan B - will speak with FDA panelists on December 16. "The idea of over-the-counter (sales) is to increase education and increase access," Barr spokeswoman Carol Cox told Bloomberg News.

EC, a concentrated dose of birth control hormones, is up to 95 percent effective at preventing pregnancy if taken within 72 hours of unprotected intercourse, contraception failure, or rape. The Feminist Majority Foundation joins a host of other reproductive health and rights groups, including the American College of Obstetricians and Gynecologists (ACOG) and the American Medical Association, in advocating FDA approval for over-the-counter status. Women's Capital Corporation submitted a request to the FDA last April for over-the-counter status of EC.

The New York state Comptroller's office released a report last week estimating that increased access to EC could save the state $452 million annually in health care costs, according to Kaisernetwork.org. Using actual Medicaid and representative private health insurance data, state Comptroller Alan Hevesi found nearly 60 percent of pregnancies in New York in 2000 were unintended, with the majority resulting in abortion. "Easy access to emergency contraception is a win for everyone. Women avoid pregnancies and abortions they don't want. And rapidly rising Medicaid costs will be cut by $254 million a year, saving money for the State and local governments. In addition, private insurers would save nearly $200 million," Hevesi said, according to his office's press release. Still, only 54 percent of pharmacies statewide carry EC. Among the report's recommendations are: permission for pharmacists to dispense EC under advance and/or phone prescriptions; support for FDA approval of over-the-counter EC status, and $10 million a year for five years to expand public education and awareness of EC.

TAKE ACTION Demand Emergency Contraception Over-the-Counter

DONATE to the Feminist Majority Foundation and support our work for women's reproductive rights

Media Resources: Kaisernetwork.org 11/10/03; Bloomberg News 11/8/03; Newsday 11/10/03; Feminist Daily News Wire


© Feminist Majority Foundation, publisher of Ms. magazine

If you liked this story, consider making a tax-deductible donation to support Ms. magazine.

 

 

Send to a Friend
Their
Your
Comments
(optional)


More Feminist News

12/16/2014 Federal Lawsuit Challenges the Wisconsin Law That's Putting Pregnant Women in Prison - A federal civil rights lawsuit is being filed on behalf of a Wisconsin woman who was jailed after allegedly using methamphetamines while 14 weeks pregnant. Tamara Loertscher, 30, was jailed after seeking prenatal care at a Mayo Clinic branch in Eau Claire, Wisconsin. . . .
 
12/16/2014 Personhood Groups Plan to Launch County and Municipal Measures to Restrict Abortion Access - A newly-created anti-abortion group has announced a new tactic meant to end abortion access nationwide. In the wake of major defeats for personhood ballot measures in Colorado and North Dakota's recent elections, anti-abortion extremist Gualberto Garcia Jones, who authored Colorado's failed Amendment 67, is now instructing groups to abandon statewide votes for personhood amendments. . . .
 
12/16/2014 Thousands Marched for Justice in Washington, DC in the Wake of Fatal Police Violence - On Saturday, December 13, the National Action Network (NAN), NAACP, and other civil rights organizations led the Justice For All March in Washington, DC. . . .